Converge International has acquired HeadUp Labs

The shareholders of HeadUp Labs have sold the company to Converge International. The acquisition of HeadUp is a strong fit with Converge’s digital product growth strategy, and has the potential to create a fully integrated and holistic preventative workplace mental health, safety, wellbeing and engagement product.

Converge is Australia’s most established B2B workplace mental health and wellbeing service provider, enabling corporate and government organizations to provide their employees with the wellbeing support they need, reducing risk, improving employee resilience and increasing workforce participation.

Headquartered in Melbourne, Australia, HeadUp Labs is a physical and mental digital health platform. It harnesses the power of wearable technology, data science, AI and machine learning to help employees and policy holders identify the areas of their health that they need to improve. HeadUp Labs has offices around the world and the team has 20+ years of experience in healthtech and insurtech.

Oaklins’ team in Australia acted as M&A advisor to Converge International on the acquisition of HeadUp Labs.

Servicio

M&A buy-side

Partes

“From the commencement of the engagement with Oaklins, we were delighted by the speed with which they were able to grasp Converge’s vision and strategy, understand and provide advice on the ‘buy’ vs ‘build’ options and identify highly synergistic value-adding acquisition opportunities, the best sources of capital, and act on behalf of Converge to progressively finetune the approach and support the buy-side and investor negotiations. At all times, the team provided Converge with advice that was proactive, wise and transparent. It has been a genuine partnership which we look forward to continuing with them as we seek further M&A opportunities to support our growth.”

Terry Winters

Chairman, Converge International

Contáctese con el equipo de la transacción

Scott McInnes

Director Ejecutivo

Melbourne, Australia
Oaklins Henslow

Ver perfil Ponte en contacto

Transacciones relacionadas

Xiel Limited has been acquired by MIS Healthcare

Private Equity | Salud

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Conozca más

Bayer AG has entered into a takeover agreement with Cara Care

Salud | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Conozca más

Grupo Veta 2017 S.L. has been acquired by MSA Mizar

Private Equity | Servicios de Soporte Comercial | Servicios Financieros | TMT

Grupo Veta 2017 S.L. has been acquired by MSA Mizar

The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.

Conozca más